Your session is about to expire
← Back to Search
Intervention as adjunct to Treatment as Usual for Opioid Use Disorder (MMORE Trial)
N/A
Waitlist Available
Led By Sarah E Lord
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 8 weeks, and 3-months postpartum
Awards & highlights
MMORE Trial Summary
This trialtests if yoga & mindfulness can help pregnant & parenting women with OUD during perinatal services & medication treatment.
Eligible Conditions
- Opioid Use Disorder
MMORE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 8 weeks, and 3-months postpartum
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 8 weeks, and 3-months postpartum
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in opioid abstinence from baseline as assessed by number of weeks consistently abstinent from opioids as determined by weekly point of care urine toxicology screening conducted as part of treatment as usual.
Retention in medication treatment for opioid use disorder as assessed by number of weeks buprenorphine or methadone present in urine toxicology screening in clinical record conducted as part of treatment as usual.
Secondary outcome measures
Change in anxiety from baseline, as assessed with the Generalized Anxiety Disorder Scale (GAD)
Change in depression from baseline, as assessed with the Edinburgh Prenatal and Postnatal Depression Scale.
Change in mindfulness from baseline, as assessed with the Mindful Attention Awareness Scale (MAAS)
+3 moreOther outcome measures
Change from baseline in quality of life measured by the World Health Organization (WHO) Quality of Life Brief.
Change in pain perception from baseline, as measured by the visual analog scale (VAS)
MMORE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention as adjunct to Treatment as UsualExperimental Treatment1 Intervention
Participants will attend via Zoom an 8-session group-based yoga-mindfulness intervention offered over the course of approximately 10 consecutive weeks. Participants will also be asked to use a mobile companion app once a week during the intervention period. All intervention participants also receive treatment as usual for OUD at the partner practice, which includes medication for OUD, individual and/or group counseling, and case management.
Group II: Treatment as UsualActive Control1 Intervention
Participants receive treatment as usual for OUD at the partner practice, which includes medication for OUD, individual and/or group counseling, and case management.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindful Moms Yoga Mindfulness Intervention
2022
N/A
~10
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
528 Previous Clinical Trials
2,541,372 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
837 Previous Clinical Trials
669,739 Total Patients Enrolled
Trustees of Dartmouth CollegeOTHER
24 Previous Clinical Trials
10,741 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are receiving medical treatment for opioid addiction during pregnancy at a specific healthcare provider.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention as adjunct to Treatment as Usual
- Group 2: Treatment as Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger